home / stock / mdma:cc / mdma:cc news

MDMA:CC News and Press, Pharmala Biotech Holdings Inc.

Stock Information
Company Name: Pharmala Biotech Holdings Inc.
Stock Symbol: MDMA:CC
Market: CNQC
Website: pharmala.ca
Menu
MDMA:CC MDMA:CC Quote MDMA:CC Short MDMA:CC News MDMA:CC Articles MDMA:CC Message Board
Get MDMA:CC Alerts

News, Short Squeeze, Breakout and More Instantly...
MDMA:CC - Canadian Companies Moving the Markets, Morning edition
Wed, Jun 05, 2024 as of 10.00 am ET

A look at the top 10 most actives in Canada Mackenzie Core Plus Canadian Fixed Income ETF (MKB) rose 0.2% to $18.9 on volume of 6,565,300 shares Suncor Energy Inc. (SU) rose 0.7% to $51.82 on volume of 3,907,645 shares iShares S&P/TSX Capped Energy Index ETF (XEG) rose 0.7% to $18.24 ...
MDMA:CC - PharmAla Launches Prescriber's Portal for Medical Professionals Focused on MDMA Therapy

TORONTO, May 03, 2024 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. (“ PharmAla ” or the “ Company ”) (CSE: MDMA) (OTC:MDXXF), a biotechnology company focused on the research, development, and manufacturing of LaNeo™ MDMA and novel derivatives of MD...

MDMA:CC - PharmAla Biotech Advances Global MDMA Production and Research

--News Direct-- PharmAla Biotech Nick Kadysh joined Steve Darling from Proactive to share exciting developments, announcing significant milestones achieved by the company's joint venture, Cortexa Pty., in Australia. Cortexa has commenced batch manufacturing of GMP LaNeo MDMA 40mg capsules...

MDMA:CC - PharmAla Closes Private Placement and Concurrent Debt Settlement

VANCOUVER, British Columbia, April 19, 2024 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. (“ PharmAla ” or the “ Company ”) (CSE: MDMA) (OTC: MDXXF), a biotechnology company focused on the research, development, and manufacturing of LaNeo™ MDMA and ...
MDMA:CC - PharmAla Announces Private Placement and Concurrent Debt Settlement

VANCOUVER, British Columbia, April 10, 2024 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. (“ PharmAla ” or the “ Company ”) (CSE: MDMA) (OTC: MDXXF), a biotechnology company focused on the research, development, and manufacturing of LaNeo™ MDMA and ...

MDMA:CC - Cortexa Commences Manufacturing GMP LaNeo(TM) MDMA in Australia

TORONTO, April 05, 2024 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. (“ PharmAla ” or the “ Company ”) (CSE: MDMA) (OTC:MDXXF), a biotechnology company focused on the research, development, and manufacturing of LaNeo™ MDMA and novel derivatives of ...

MDMA:CC - Patent Allowance Granted for ALA-002 Composition by US Patent and Trademark Office

TORONTO, March 27, 2024 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. (“ PharmAla ” or the “ Company ”) (CSE: MDMA) (OTC:MDXXF), a biotechnology company focused on the research, development, and manufacturing of LaNeo™ MDMA and novel derivatives of ...
MDMA:CC - PharmAla Biotech Signs Sale Agreement with Numinus

TORONTO, March 26, 2024 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. (“ PharmAla ” or the “ Company ”) (CSE: MDMA, OTC:MDXXF), a biotechnology company focused on the research, development, and manufacturing of LaNeo™ MDMA and novel derivatives of M...

MDMA:CC - Patent Allowance Granted for P-1 Molecule by US Patent and Trademark Office

TORONTO, March 20, 2024 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. (“ PharmAla ” or the “ Company ”) (CSE: MDMA) (OTC:MDXXF), a biotechnology company focused on the research, development, and manufacturing of LaNeo™ MDMA and novel derivatives of ...

MDMA:CC - Cortexa Leads the World in First Supply of Psilocybin Under the TGA's Authorized Prescriber Scheme

VANCOUVER, British Columbia, March 18, 2024 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. (“ PharmAla ” or the “ Company ”) (CSE: MDMA) (OTC:MDXXF), a biotechnology company focused on the research, development, and manufacturing of LaNeo™ MDMA and n...
Next 10